Medicure Inc.
MPH.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 22.90% | 26.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.90% | 26.14% | |||
| Cost of Revenue | 67.30% | 27.02% | |||
| Gross Profit | -18.91% | 25.33% | |||
| SG&A Expenses | -0.34% | 20.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.10% | 24.76% | |||
| Operating Income | -88.26% | -12.94% | |||
| Income Before Tax | -83.92% | -15.12% | |||
| Income Tax Expenses | 9.07% | 58.11% | |||
| Earnings from Continuing Operations | -78.42% | -17.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -78.42% | -17.47% | |||
| EBIT | -88.26% | -12.94% | |||
| EBITDA | -349.71% | -59.92% | |||
| EPS Basic | -78.49% | -17.49% | |||
| Normalized Basic EPS | -84.13% | -17.54% | |||
| EPS Diluted | -67.99% | -18.44% | |||
| Normalized Diluted EPS | -84.13% | -17.54% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||